Announced Thu, 13 Aug · 14:23 IST
FDC subsidiary gets UK MHRA approval for Atropine eye drops
FDC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.3%1-day move
₹354.70
prior close
₹358.35
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.4-0.2-0.2+0.4+0.3-0.2-0.9-2.5-1.1—————
Up moveDown movePending
AI summary
FDC Limited's subsidiary FDC International Limited has received Marketing Authorisation from the UK's MHRA for Atropine 1.0 percent w/v Eye Drops Solution. MHRA approval allows the subsidiary to market and sell this ophthalmic product in the United Kingdom, giving FDC a regulatory pathway into the UK pharmaceutical market for Atropine eye drops.
Likely market impact
Positive. UK clearance lets FDC subsidiary commercialise Atropine eye drops in Britain, supporting future export revenue from a hard-currency market.